Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Pharmaceutical Development and Technology
|
September 22, 1998
Purified guar galactomannan as an improved pharmaceutical excipient
M S Gebert, D R Friend
Contraception
|
July 1, 1989
Transdermal delivery of levonorgestrel. VII. In vivo studies
D R Friend, P Catz, S Phillips
Journal of Pharmaceutical Sciences
|
June 1, 1995
Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis
H Nolen, R N Fedorak, D R Friend
Gut
|
October 1, 1994
A budesonide prodrug accelerates treatment of colitis in rats
N Cui, D R Friend, R N Fedorak
Biopharmaceutics & Drug Disposition
|
November 28, 1997
Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats
H W Nolen, R N Fedorak, D R Friend
Journal of Pharmaceutical Sciences
|
June 1, 1989
Transdermal delivery of levonorgestrel. IV: Evaluation of membranes
D R Friend, P Catz, J Heller, et al.
Drug Design and Delivery
|
October 1, 1990
Effect of antibiotic pretreatment on glycoside/glycosidase-based colonic drug delivery
D R Friend, J J Chow, G W Chang
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
September 1, 1991
Cutaneous effects of transdermal levonorgestrel
D R Friend, S J Phillips, J R Hill
Journal of Pharmaceutical Sciences
|
September 1, 1994
Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents
A D McLeod, D R Friend, T N Tozer
Pharmaceutical Research
|
November 1, 1989
Transdermal delivery of levonorgestrel. V. Preparation of devices and evaluation in vitro
D R Friend, P Catz, J Heller, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Pharmaceutical Development and Technology
|
September 22, 1998
Purified guar galactomannan as an improved pharmaceutical excipient
M S Gebert, D R Friend
Contraception
|
July 1, 1989
Transdermal delivery of levonorgestrel. VII. In vivo studies
D R Friend, P Catz, S Phillips
Journal of Pharmaceutical Sciences
|
June 1, 1995
Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis
H Nolen, R N Fedorak, D R Friend
Gut
|
October 1, 1994
A budesonide prodrug accelerates treatment of colitis in rats
N Cui, D R Friend, R N Fedorak
Biopharmaceutics & Drug Disposition
|
November 28, 1997
Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats
H W Nolen, R N Fedorak, D R Friend
Journal of Pharmaceutical Sciences
|
June 1, 1989
Transdermal delivery of levonorgestrel. IV: Evaluation of membranes
D R Friend, P Catz, J Heller, et al.
Drug Design and Delivery
|
October 1, 1990
Effect of antibiotic pretreatment on glycoside/glycosidase-based colonic drug delivery
D R Friend, J J Chow, G W Chang
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
September 1, 1991
Cutaneous effects of transdermal levonorgestrel
D R Friend, S J Phillips, J R Hill
Journal of Pharmaceutical Sciences
|
September 1, 1994
Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents
A D McLeod, D R Friend, T N Tozer
Pharmaceutical Research
|
November 1, 1989
Transdermal delivery of levonorgestrel. V. Preparation of devices and evaluation in vitro
D R Friend, P Catz, J Heller, et al.
Page
of 4